-
As of early October 2025, drug-resistant bacterial infections, especially those carrying the NDM gene, have surged sharply in the US, with cases rising over fivefold since 2019. Australian researchers developed a new phage therapy targeting Enterobacter infections. In Asia, resistant bacteria cause nearly 80% of newborn sepsis cases, while Kerala, India, faces a deadly outbreak of brain-eating amoeba infections. West Nile virus and mosquito-borne diseases also rise in the US and Europe.
-
Australia faces a shortage of registered stem cell donors, relying heavily on overseas donors. Young Australians are encouraged to donate, with procedures now less invasive. Meanwhile, stories from India and the UAE highlight individual acts of donation and successful transplants, emphasizing the importance of awareness and registry growth.
-
Starting October 12, 2025, 29 Schengen countries began implementing the Entry/Exit System (EES), replacing manual passport stamps with biometric checks for non-EU travelers. The system records fingerprints and facial images at first entry, storing data for three years to streamline border control and monitor 90-day stay limits. Full rollout completes by April 10, 2026.
-
At least 19 children in Madhya Pradesh died after consuming a contaminated cough syrup, Coldrif, produced by Sresan Pharmaceuticals. Tests confirmed the presence of toxic diethylene glycol at levels far exceeding safety limits. Authorities have banned the product and launched investigations into manufacturing and supply chains. The incident revives concerns over India's pharmaceutical regulation and safety standards.
-
As of late October 2025, Hong Kong reports its first locally acquired chikungunya case, prompting intensified mosquito control in Diamond Hill. Meanwhile, the US and UK detect local transmission of mpox clade Ib, primarily outside traditional risk groups. Authorities emphasize vaccination, mosquito control, and public awareness to curb spread amid seasonal mosquito inactivity.